Riskpilot← Back to searchSign inGet full accessEDENTATIO Aktiebolag
ABActiveOrg 5563340552Bansviksberget 5Medical specialists activities · NACE 8622Est. 19880 employees
Revenue 2025
SEK 114K
-33% vs 2024
EBITDA margin
-298.3%
+71% vs 2024
Equity ratio
96.2%
Financial strength
Net profit 2025
SEK 469K
+128% vs 2024
| Revenue | SEK 114K | -33% |
| EBITDA | SEK -340K | +71% |
| Net profit | SEK 469K | +128% |
| Total assets | SEK 1,9M | -10% |
| Equity | SEK 1,8M | -7% |
| Employees | 0 | — |
Legal name
EDENTATIO Aktiebolag
Org number
5563340552
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 oktober 1988
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva käk-kirurgisk vård och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Bansviksberget 5
Email
mats.hellman@edentatio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 298 | 1 960 | 158 | 171 | 114 |
| Staff expenses | — | — | −845 | −674 | −235 |
| EBITDA | −820 | −780 | −1 023 | −1 192 | −340 |
| Depreciation & amort. | −158 | −156 | −144 | −146 | −9 |
| EBIT | −978 | −936 | −1 167 | −1 338 | −349 |
| Net financials | 1 295 | 1 494 | 1 543 | 1 544 | 818 |
| Profit before tax | 317 | 558 | 376 | 206 | 469 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 317 | 558 | 376 | 206 | 469 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 088 | 1 572 | 2 455 | 2 072 | 1 871 |
| Equity | 791 | 1 349 | 1 725 | 1 930 | 1 799 |
| Long-term debt | 50 | 0 | 553 | 0 | — |
| Short-term debt | 1 248 | 223 | 177 | 141 | 72 |
| Total debt | 1 298 | 223 | 731 | 141 | 72 |
EBITDA margin
-298.3%
This company
15.8%
Market median
-1988% vs market
20212025
Equity ratio
96.2%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
26.1%
This company
18.4%
Market median
+42% vs market
20212025
Net profit margin
411.6%
This company
8.1%
Market median
+4981% vs market
20212025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Former (3) | ||
SL Chief Auditor | Chief Auditor | 2022 – 2024 |
BE Chief Auditor | Chief Auditor | 2022 – 2022 |
EK Chief Auditor | Chief Auditor | 2024 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bone Friend Holding AB
EDENTATIO Aktiebolag Board members of EDENTATIO Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stig Lennart Christer Holmstrand | Chief Auditor | 0 companies |
| Björn Erik Lennart Andersson | Chief Auditor | 0 companies |
| Elina Karin Linnéa Madsen | Chief Auditor | 0 companies |
| Björn Mats Hellman | Deputy Board Member | 0 companies |
| Nils Mats Hellman | Board of Directors | 0 companies |